D D Breimer

Relevance of the Application of Pharmacokinetic-Pharmacodynamic Modelling Concepts in Drug Development

M Danhof, D D Breimer, M. Danhof, 1997, Clinical pharmacokinetics.

A computer-based international 'thesis-line'?

D D Breimer, L H Breimer, 1995, Trends in biochemical sciences.

The blood-brain barrier in neuroinflammatory diseases.

D D Breimer, H. D. de Vries, T. V. van Berkel, 1997, Pharmacological reviews.

The Blood-Brain Barrier: Clinical Implications for Drug Delivery to the Brain

D D Breimer, D. Breimer, A G De Boer, 1994, Journal of the Royal College of Physicians of London.

Future challenges for drug delivery.

D D Breimer, D. Breimer, 1999, Journal of controlled release : official journal of the Controlled Release Society.

Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier.

D D Breimer, J. Wijnholds, P. Borst, 2000, The Journal of clinical investigation.

Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.

M Danhof, D D Breimer, M. Danhof, 1988, The Journal of pharmacology and experimental therapeutics.